Contact

Our portfolio

Cellagenics

Cellagenics

Developing STEP® technology, Cellagenics scales up therapeutic antibody production in mammalian cell lines. Their collaboration with Batavia Biosciences aims to enhance biopharmaceutical manufacturing.

  • Institute: University of Amsterdam
Industry: Therapeutics
  • Founding year: 2008
Visit website

Want to get in contact about Cellagenics?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Ross Gordon

Chemistry, Biotech & AI

Our portfolio

Check out similar ventures

DCPrime
Pioneering cancer vaccines, DCPrime leverages its DCOne® dendritic cell technology to develop innovative immunotherapies.
TrianecT
Innovating stroke diagnosis with an AI-powered portable EEG for use inside the ambulance.
Kling Biotherapeutics
Discovering novel antibodies for cancer and infectious disease treatments.
Arthrogen
Developing local gene therapy for chronic diseases, Arthrogen utilizes viral-mediated gene transfer to treat conditions like rheumatoid arthritis.
DCPrime
Pioneering cancer vaccines, DCPrime leverages its DCOne® dendritic cell technology to develop innovative immunotherapies.
TrianecT
Innovating stroke diagnosis with an AI-powered portable EEG for use inside the ambulance.
Kling Biotherapeutics
Discovering novel antibodies for cancer and infectious disease treatments.
Arthrogen
Developing local gene therapy for chronic diseases, Arthrogen utilizes viral-mediated gene transfer to treat conditions like rheumatoid arthritis.
Explore full AAV portfolio
Contact